1. Screening, diagnosis and management of human cysticercosis andTaenia soliumtaeniasis: technical recommendations by the COHEMI project study group
- Author
-
Zammarchi, Lorenzo, Bonati, Maurizio, Strohmeyer, Marianne, Albonico, Marco, Requena-Méndez, Ana, Bisoffi, Zeno, Nicoletti, Alessandra, García, Hector H., Bartoloni, Alessandro, Pandolfini, Chiara, Severino, Francesca, Confalonieri, Valeria, Tognoni, Gianni, Buonfrate, Dora, Angheben, Andrea, Bartalesi, Filippo, Muñoz, Jose, Roura, Maria, Ventura, Laia, Pool, Robert, Pell, Christopher, Hardon, Anita, Chiodini, Peter, Moreira, Juan, Anselmi, Mariella, Sempértegui, Roberto, Gotuzzo, Eduardo, Mena, Maria Alejandra, Liendo, Carola, Garcia, Héctor H., Bustos, Javier, Santivañez, Saul, Torrico, Faustino, Lozano, Daniel, Cabrera, Teresa Hinojosa, Morón, Javier Ochoa, Cuellar, Ignacio Abapori, Suarez, Jaime Amorós, Rojas, Guido Chumiray, and Bruno, Elisa
- Subjects
Recommandations ,Neurocysticercosis ,Disease ,cysticercosis ,epilepsy ,neurocysticercosis ,recommendations ,Taenia solium ,taeniasis ,Animals ,Antiparasitic Agents ,Cysticercosis ,Europe ,Humans ,Latin America ,Transients and Migrants ,Parasitology ,Public Health, Environmental and Occupational Health ,Infectious Diseases ,0302 clinical medicine ,Cysticercosis/diagnosis/drug therapy ,Taeniasis ,neurocysticercose ,neurocisticercosis ,teniase ,3. Good health ,medicine.drug_formulation_ingredient ,cysticercose ,Public Health ,purl.org/pe-repo/ocde/ford#3.03.06 [https] ,medicine.medical_specialty ,030231 tropical medicine ,Developing country ,cisticercosis ,Epilepsia ,03 medical and health sciences ,Environmental health ,parasitic diseases ,medicine ,business.industry ,Environmental and Occupational Health ,teniasis ,Taenia solium taeniasis ,medicine.disease ,Surgery ,Taenia solium/isolation & purification ,Recomendaciones ,epilepsie ,business ,Antiparasitic Agents/therapeutic use ,Healthcare providers ,030217 neurology & neurosurgery - Abstract
Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.
- Published
- 2017